FIT4MOM Launches “Milk Mission” to Connect Moms Around the U.S. Affected by the Baby Formula Shortage

FIT4MOM, a leading wellness company for moms, launched Moms With A Mission: Milk Mission in response to the current baby formula shortage. FIT4MOM’s mission begins with providing connections and support for all moms.

FIT4MOM has recently witnessed the pain, stress, and fear this crisis has caused the moms in their communities, so Moms With A Mission: Milk Mission was formed to help during this heartbreaking time.

Moms With A Mission: Milk Mission is a national online group dedicated to connecting those affected by the shortage with those wanting to help. The group provides a central location for parents, caregivers, and community members across the nation to share store locations, resources, and support for those in search of baby formula. FIT4MOM is committed to supporting parents so no baby goes hungry, and is dedicating resources to closely monitor the group to ensure it’s a safe space for all.

“As a company whose values are deeply rooted in supporting moms and their families, we knew we needed to help however we could,” FIT4MOM founder and CEO, Lisa Druxman. “No baby should go hungry and we are committed to this mission and doing whatever we can to help during this time.”

With nearly 2,000 individual class locations, 1,850 instructors, and 300 franchise owners nationwide, FIT4MOM reaches tens of thousands of moms all over the United States every day. Through Moms With A Mission: Milk Mission, FIT4MOM aims to unite, connect, and support these moms and other parents around the nation affected by this crisis.

Click here to join the Moms With A Mission: Milk Mission online group. To learn more about FIT4MOM, their franchising and instructor opportunities, or to find a class near you, please visit fit4mom.com.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version